No Data
Fresenius's Exit of Vamed Business Is a Positive -- Market Talk
0944 GMT - Fresenius's initiation to exit its Vamed business, seen as a drag on profitability, should be welcomed by investors, Berenberg analysts say in a note. The analysts estimate that the divestm
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
Correction to Fresenius Medical Care Article on Tuesday
Fresenius Medical Care reported results for the first quarter. "Fresenius Medical Care Shares Drop on Profit Fall," at 0855 GMT on Tuesday, misstated the company name in the third paragraph.
Fresenius Shares Rise After Guidance Lift, Vamed Exit
By Helena Smolak Fresenius shares rose after the company lifted its full-year guidance on rising first-quarter net profit that beat expectations and said it started the exit from its investment compa
Fresenius Medical Care First Quarter 2024 Earnings: EPS Beats Expectations
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target price of $17, implyin